Final ID: WP215
Naghavi Morteza, Wong Nathan, Vliegenthart Rozemarijn, Mcconnell Michael, Maron David, Branch Andrea, Kloner Robert, Mechanick Jeffrey, Ma Ning, Yip Rowena, Fan Wenjun, Azimi Amir, Roy Sion, Nasir Khurram, Molloi Sabee, Fayad Zahi, Kakadiaris Ioannis, Abela George, Narula Jagat, Williams Kim, Shah Prediman, Benjamin Emelia, Atlas Kyle, Levy Daniel, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Yankelevitz David, Mirjalili Seyed Reza, Henschke Claudia
A Phase 2 Study Evaluating the Effects of Mivelsiran, an Investigational RNA Interference Therapeutic, on Hemorrhagic and Nonhemorrhagic Manifestations of Cerebral Amyloid AngiopathyGreenberg Steven, Parikh Neal, Lee Jin-moo, Van Etten Ellis, Van Osch Matthias, Klijn Catharina, Sostelly Alexandre, Goteti Sasikiran, Sepehrband Farshid, Avbersek Andreja, Deering Robert
We encourage you to enter the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.
You have to be authorized to post a comment. Please, Login or Signup.